Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00915551 · ClinicalTrials.gov registry record · Phase 3
A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
A Phase 3 study, sponsored by Peplin.
- Completed
- Registry status
- Phase 3
- Development phase
- 278
- Enrollment target
NCT00915551: Completed Phase 3 study, sponsored by Peplin.
NCT00915551 is a Phase 3 study that has completed, run by Peplin. The registered enrollment target is 278 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00915551, a Phase 3 study, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 278 participants
- Enrollment target
Study Summary
This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when applied to an area of skin containing 4-8 AK lesions on the face or scalp.
Primary Outcome
Complete clearance of the treatment field
Interventions
- DRUG Vehicle Gel
- DRUG PEP005 (Ingenol Mebutate) gel, 0.015%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2009-06 |
| Est. Completion | 2009-09 |
| Phase | Phase 3 |
What the finished NCT00915551 record still lists
NCT00915551 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 2 interventions - of which Vehicle Gel is the first listed.
NCT00915551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00915551 about?
NCT00915551 is a clinical study titled "A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)". This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when applied to an area of skin containing 4-8 AK lesions on the face or scalp.
What is the current status of trial NCT00915551?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 278 participants. The study started on 2009-06. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00915551?
The interventions under investigation include: Vehicle Gel (DRUG), PEP005 (Ingenol Mebutate) gel, 0.015% (DRUG).
Who is sponsoring clinical trial NCT00915551?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00915551's enrollment target sits among peer trials
278 1200th of 2000 higher than 799 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
- NCT05489237 · 278 participants · Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
- NCT05965245 · 278 participants · NA
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia